Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt

BSE1557.15141.55 (+10 %)

PREV CLOSE ( ) 1415.60

OPEN PRICE ( ) 1490.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 78224

TODAY'S LOW / HIGH ( )1440.00 1557.15

52 WK LOW / HIGH ( )421 1580

NSE1558.55141.65 (+10 %)

PREV CLOSE( ) 1416.90

OPEN PRICE ( ) 1490.00

BID PRICE (QTY) 1558.55 (96600)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1616248

TODAY'S LOW / HIGH( ) 1441.00 1558.55

52 WK LOW / HIGH ( )420 1582.95

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-07 1999

Management Info

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office

Address D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone 0240-6632222 / 6694444

Email investorrelations@wockhardt.com

Website www.wockhardt.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

31Jan Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..

14Jan Wockhardt informs about compliance cer
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..

13Jan Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..

03Jan Wockhardt secures approval from CDSCO
Wockhardt has received an approval from the Indian drug regulator, Centr..

03Jan Wockhardt zooms on securing approval f
Wockhardt is currently trading at Rs. 1538.00, up by 92.25 points or 6.3..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	-360	-4220
Gross Profit	-360	-4220
Operating Profit	600	50
Net Sales	3700	11540

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 7441.40 (2.96%)	M.Cap ( in Cr)18603.50
Medplus Health Servi (BSE) 787.20 (8.64%)	M.Cap ( in Cr)9422.30
Suven Pharma (BSE) 1108.25 (4.99%)	M.Cap ( in Cr)28212.16
Bajaj Healthcare (BSE) 690.80 (8.20%)	M.Cap ( in Cr)2181.77
Divi's Lab (BSE) 5622.30 (0.83%)	M.Cap ( in Cr)149254.40

Shareholding Pattern

	PROMOTERS	49.09%
	NON-INSTITUTION	34.53%
	MUTUAL FUNDS/UTI	7.13%
	FI/BANKS/INSURANCE	0.47%
	GOVERNMENT	0.02%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco Active Moment...	10.21
ITI Focused Equity ...	4.01
HDFC Pharma and Hea...	3.08
Tata India Pharma &...	3.02
Samco Special Oppor...	2.85
Mirae Asset Healthc...	2.84
Samco Dynamic Asset...	2.07

Risk Disclosures on Derivatives

Smart Quotes

WOCKHARDT LTD.